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ABSTRACT
The herpes simplex virus type 1 regulatory protein ICP4
is a sequence specific DNA binding protein which
associates with a number of different sites, some of
which include the consensus ATCGTCnnnnYCGRC. In
order to investigate the involvement in DNA binding of
conserved bases within the consensus, we have
synthesised a family of mutant oligonucleotides and
tested their ability to form a complex with ICP4. We
have also compared the binding specificities of
bacterially expressed fragments of ICP4 which include
the DNA binding domain. Mutation of most (but not all)
bases In the proximal part of the consensus greatly
reduced binding by ICP4, as did a mutation affecting
the distal part. Most (but not all) G residues identified
in methylatlon interference assays were required for
efficient binding. While a bacterially expressed ICP4
peptide encompassing amino acid residues 252 - 523
bound to DNA with a specificity similar to that of the
whole protein, a shorter protein (residues 275 - 523)
had a slightly relaxed DNA binding specificity.
INTRODUCTION
Analysis of the complete 150kb DNA sequence of heipes simplex
virus type 1 (HSV-1) has predicted the presence of at least 70
distinct genes (1). These genes can be grouped into three principal
temporally regulated groups depending on the kinetics and drug-
sensitivity of their expression during virus infection in tissue
culture (see references 2, 3 and 4 for reviews). The immediate-
early (IE) genes can be transcribed in the absence of viral protein
synthesis, while transcription of the later classes of genes requires
IE polypeptide synthesis. Perhaps the most important of the IE
polypeptides is ICP4 (also known as Vmwl75) since it is
absolutely required for progression of the lytic cycle beyond the
IE phase (5,6).
ICP4 is a sequence specific DNA binding protein which
recognises a number of sites throughout the HSV-1 genome
(7 -14). These sites appear to conform to either of two classes,
firstly the so-called consensus sites which include the sequence
ATCGTCnnnnYCGRC, first recognised by Faber and Wilcox
(8). This consensus can be viewed as two conserved portions
separated by a variable region. In addition, there are a number
of other sites whose relationship to the consensus is not clear
(13-15).
While there are several reports which suggest that the ability
of ICP4 to bind to DNA is important for its functions (16-18),
the role of individual binding sites is not so clear-cut. For
example, while the binding site at the cap site of gene IE-3 is
important for repression of the IE-3 promoter in transfection
assays (19, 20) the role of other binding sites in the ability of
ICP4 to activate early promoters is more controversial (13, 15,
21, 22). One problem in the interpretation of the role of ICP4
binding sites is that, given the variation in their sequence, it is
not possible to predict from sequence data alone whether a site
will be recognised or not. Therefore, in order to establish a
greater understanding of the characteristics of an ICP4 binding
site, we have undertaken a mutan'onal analysis of the well- defined
consensus site found upstream of the glycoprotein gD promoter
region. We found that while mutation of several of the conserved
residues in the proximal part of the site greatly reduced binding,
not all such residues were essential. In addition, the distal part
of the consensus sequence was found to be as important as the
proximal.
As a first step towards determining the amino acid residues
of ICP4 which are involved in sequence specific binding, we have
expressed portions of the DNA binding domain in bacteria. Using
the family of mutant oligonucleotide probes, it was found that
one bacterially expressed peptide had a DNA binding specificity
indistinguishable from that of the intact protein made in infected
cells. However, a slightly smaller portion of the protein was
somewhat less rigorous in its requirements for sequence specific
binding.
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MATERIALS AND METHODS
Oligonucleotides and preparation of probes
A double stranded oligonucleotide corresponding to positions
— 89 to-110 of the gD promoter (with four nucleotide 5' single-
standed extensions identical to those produced by restriction
enzymes Sail and Xhol) was synthesised to create a probe of wild
type sequence:
5' TCGACACTATCGTCCATACCGACCAC 3'
Mutant probes based on this sequence were also synthesised, as
detailed in Figure 1. Further oligonucleotides containing the
sequences between coordinates —109 to - 9 2 , and — % to —79
(see Figure 1) were also synthesised, again with Sail and Xhol
cohesive ends. After synthesis, the single-stranded
oligonucleotides were annealed in appropriate pairs and purified
by gel electrophoresis. Double-stranded oligonucleotides were
labelled either with -y-32P ATP and polynucleotide kinase or
with a-32P dATP and Klenow polymerase. Labelled probes
were again purified by gel electrophoresis before use.
In some experiments the 47bp fragment between coordinates
—121 and —82 was used either as a probe or as a competitor.
The Xmam-Hinfl 47bp fragment from pJB3 (13) was isolated,
mixed with Xhol linker oligonucleotides and ligated into the Xhol
site of pAgDCAT (22). Large scale plasmid preparations cut with
Xhol yielded mg quantities of the 47bp fragment, which was
purified by gel electrophoresis and quantitated by UV adsorbance.
Labelled 47bp fragment probes were prepared using a-32P
dATP and Klenow DNA polymerase.
Gel retardation assays
A. Using intact ICP4 expressed during virus infection. Labelled
oligonucleotide probes (0.5 to Ing) were incubated for 60 min
at 26°C with 3ftl infected cell nuclear extract or partially purified
ICP4 fraction VIII in 20/xl reaction mixtures which also contained
lOmM Tris-HCl (pH 7.6), 15mM KC1, 15/iM EDTA, 0.1%
NP40 and 250-400ng of Escherichia coli lac operator DNA as
non-specific competitor. The procedures for separating the bound
and unbound probe complexes on non-denaturing acrylamide gels
have been described previously (13). The fraction of probe in
the bound complex was determined by excision of the bands
followed by liquid scintillation counting.
B. Using fragments of ICP4 expressed in bacteria. Suitable
dilutions of bacterial extracts were mixed with approximately
0. Ing of Klenow-labelled oligonucleotide probes on ice in a buffer
containing lOmM Tris-HCl pH 8.0, lmM EDTA, lOOmM NaCl,
1/tg polydl/polydC and 0.1 % NP40. After incubation for 20
minutes, the mixtures were applied to a non-denaturing 4%
polyacrylamide gel with 0.5 x TBE running buffer and run at
200V at 4°C for 2 to 3 hours. Complexed and unbound probe
was detected by autoradiography of the dried gel.
Bacterial expression plasmids
The expression plasmid p585.4 (kindly provided by Dr. C. M.
Preston) is a derivative of plasmid pET-8c (23) which has a Ncol
and BamHI cloning sites for insertion of coding regions for
expression. Plasmids pI9, pIlO and pll 1 are derivatives of pl75
(24) which contain EcoRI linker insertions into ICP4 coding
sequences at codons 252, 275 and 292 respectively (25). The
EcoRI-BamHI fragments of these plasmids, which include ICP4
sequences as far as the BamHI site at codon 523, were cloned
into p585.4 between the Ncol and BamHI sites with the aid of
adaptor oligonucleotides. The adaptors allowed the linkage of
Ncol extensions to those generated by EcoRI and which
maintained the ICP4 peptide reading frame (which is initiated
at the ATG in the Ncol site). The sequences at the NcoI-EcoRI
junctions were confirmed by direct sequencing of the resultant
plasmids. The peptides expressed by these plasmids (pT7I9,
pT7I10 and pT7H 1) contain ICP4 coding sequences proceeded
by five amino acids encoded in the N-terminal junction region
(MARIR in pT7I9 and MAEFG in both pT7I10 and pT7Ill).
At the C-terminal end of these peptides there are twenty amino
acids encoded by vector DNA 3' of the BamHI site. Plasmids
pT7I9X and pT7I10X are derivatives of pT7I9 and pT7I10 which
have Xbal linker oligonucleotides containing stop codons in all
three reading frames inserted into their BamHI sites so as to
remove the vector-encoded 20 amino acid residues from the
expressed proteins.
Expression of fragments of ICP4 in bacteria and their partial
purification
The T7 expression plasmids were transformed into E. coli host
BL21 (DE3) pLysS (23) and maintained as glycerol stocks.
Bacterial colonies from a freshly streaked nutrient agar plate
containing ampicillin at 100/tg/ml were inoculated into YT-broth
containing ampicillin at 100/tg/ml and grown shaking at 37 °C
until the OD450 was about 0.5. IPTG was added to a final
concentration of 150/tg/ml and incubation continued for lhr. The
bacteria were harvested, resuspended in 1/100 volume of Tris-
HCl pH 8.0, lmM EDTA lmM PMSF and O.lmM DTT and
frozen at -20°C. After thawing, sodium deoxycholate and
lysozyme were added to final concentrations of 0.5% and
100/ig/ml respectively. After lysis NaCl was added to 2M final
concentration and the DNA pelleted by centrifugation at 20000
rpm for lhr in the Sorvall SS34 rotor. The supernatants were
made up to 25% saturation with ammonium sulphate and the
precipitated proteins pelleted, dissolved in 50mM Tris-HCl pH
7.5, lmM EDTA, 200mM NaCl, 0.1% CHAPS, lmM PMSF
and 0. lmM DTT. The extracts were dialysed against the same
buffer (but with 0.01% CHAPS), mixed with an equal volume
of glycerol and stored at -20°C.
Methylation interference assays
Either the lower or the upper strand oligonucleotide of the —109
to—92 probe was individually labelled with polynucleotide kinase,
hybridised to the unlabelled complementary strand and then
partially methylated with dimethyl sulphate. The probe was then
incubated with infected cell extract and the ICP4 bound and
unbound species separated by gel electrophoresis. The DNAs
were electroeluted, treated with 1M piperidine at 90°C for 30
min and then loaded onto a 10% polyacrylamide 8M urea DNA
sequencing gel.
Viruses, cells and nuclear extracts
The growth of HeLa cells and their infection with HSV-1 strain
KOS has been described previously (26). Nuclear extracts were
prepared by the method of Dignam et al. (27) 6 hours after
infection. Partially purified ICP4 fraction VIII (a gift from Dr.
K. Wilcox) was dialysed against Hepes-glycerol buffer D (27)
prior to use.
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RESULTS
The binding of ICP4 to site II in the gD promoter
ICP4 binding site II in the HSV-1 glycoprotein gD promoter was
initially identified by an immuno binding assay, and the DNA
binding region resolved by DNase footprinting (8) (Figure 1).
Although there is no incontrovertible evidence that such ICP4
DNA binding sites play a specific and essential role in ICP4
function, there are situations both in vivo and in vitro in which
the presence of gD site II contributes to the overall promoter
activation induced by ICP4 (13, 22).
The aim of the work described here was to investigate the
detailed DNA sequence requirements for binding at gD site II
by ICP4. Initially, a gel mobility shift assay was used to confirm
that ICP4 bound to site II. Using the 47bp Xmam-Hinfl fragment
(see Methods) as probe, increasing amounts of infected cell
nuclear extract produced increasing amounts of a slow moving
complex (arrowed). This was shown to contain ICP4 by further
retardation after incubation with the anti-ICP4 monoclonal
antibody H944 (Figure 2). The specificity of ICP4 binding was
indicated by the fact that the amount of complex formed could
be reduced by adding unlabelled probe fragment but not by E.
coli lac DNA (Figure 2, tracks I and J). Other retarded bands
observed in this experiment were not further retarded by the
antibody and were (at least to some extent) present in uninfected
cell extracts and so they are not relevant to ICP4 binding.
Inspection of the ICP4 gD site E footprint from -115 to - 7 5
reveals an imperfect axis of symmetry in which the core AT-
CGTC ICP4 binding consensus (8) is located on the 5' side while
an inverted sequence, GACGA, is located in the 3' portion. This
raises the question whether both of these sites bind ICP4 and
thus contribute to the rather large region that is protected from
the action of DNase. Accordingly, two oligonucleotide probes
were synthesised, one containing the 5' sequence from —109
to - 9 2 and the other the 3' region from - 9 6 to - 7 9 (Figure
3A). Gel retardation assays, using both infected cell nuclear
extracts and partially purified ICP4 fraction VHI, showed that
both probes formed a complex with ICP4. The 5' oligo was bound
about 3-fold more strongly than that containing the 3' side.
Formation of the ICP4 specific complexes with both
oligonucleotides was efficiently inhibited by addition of the 47bp
fragment (Figure 3B). We conclude that the 5' and 3' halves of
the gD site II region can bind ICP4 independently, although a
different approach would be necessary to determine exactly the
relative ICP4 binding affinities of the two oligonucleotides. It
should be noted that the 3' probe also contains the distal core
sequence (TGG in this instance; see below).
The fact that oligonucleotides including both the 5' and 3' sites
bind ICP4 does not necessarily mean that both sites can be bound
simultaneously. Since the sites are very close, binding to one
may preclude binding to the other. Indeed, comparison of the
mobility of the retarded complexes formed with site II and other
IE-3 IE-3
gDRNA
Site I Site II
SstI
Site III
Hindin
CACTATCGTCCATACCGACCACACCGACGAATCCCC
-111 I I -101 -91 -81
Oligo 1
Oligo 2
Oligo 3
Oligo 4
Oligo 5
Oligo 6
Oligo 7
Oligo 8
Oligo 9
A
G
T
TTA
Figure 1. A. The HSV-1 genome with the location of the gD gene and the IE-3 gene encoding ICP4 is shown, with the boxed regions representing the repeats
bounding the long and short unique regions of the genome. B. The HSV-1 gD promoter region with its three defined ICP4 specific binding sites between the Hindlll
site at +11 and the SstI site at -392. The sequence of the site II region is shown. The ATCGTC of the proximal part of the consensus starts at position -107.
Mutant oligonucleotides 1 to 8 have the indicated point mutations in the ATCGTC consensus, with the complementary mutation on the other strand. Mutant oligonucleotide
9 has a triple mutation in the distal part of the consensus. Wild type and mutant oligonucleotides included bases - 8 9 to -110 of the sequence shown here, with
TCGA 5' extensions so as to create Sail and Xhol restriction sites at their extremities.
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Figure 2. Gel mobility shift assay with the 47bp fragment gD site II probe. Purified
Xhol-cut 47bp fragment was end-labelled and incubated with increasing amounts
of infected cell extract in the presence of 3jtg Salmon sperm DNA as non-specific
competitor. The addition of monoclonal anti-ICP4 antibody, lac DNA (400ng)
or unlabelled 47bp fragment (200ng) competitor is indicated above the appropriate
lane. The percentage of DNA probe present in the ICP4 complex (which is
indicated by the arrow) is given at the foot of each lane.
binding sites (13) suggests that these sites bind the same number
of ICP4 molecules. Using a different set of binding sites, it has
been shown that normally only one dimeric ICP4 molecule binds
to each site (14). It would be difficult to prove whether there
are situations in which both 5' and 3' sites in site II can be
simultaneously occupied since increasing the amount of ICP4 in
gel retardation assays generally results in novel lower mobility
complexes (which probably contain additional ICP4 dimers),
irrespective of the probe used (data not shown).
Methylation of guanosine residues in both proximal and distal
parts of the consensus interfers with ICP4 binding
Methylation interference experiments with a DNA fragment from
the IE-3 gene indicated that ICP4 binding involved G residues
flanking the ATCGTC core (10). Figure 4 shows the result of
a methylation interference assay using both top and bottom strands
of a synthetic site II oligonucleotide containing sequences from
-109 to - 9 2 . Decreased intensity of G residues in the tracks
using DNA isolated from the ICP4 complex; compared to the
free DNA, showed that methylation of some (but not all) G
residues both within the ATCGTC core and in the distal part
of the consensus sequence interfered with binding. The summary
of the results in Figure 4c shows that the important G residues
are localised on both faces of the DNA helix, illusitrating that
in this instance bound ICP4 seems to wrap around the DNA.
Mutation of bases in both parts of the consensus inhibits
binding by ICP4
A double stranded oligonucleotide (Figure 1) was synthesised
which contains the 5' portion of the footprinted region of the
gD binding site II, which includes a single copy of the consensus
(8; see above). After labelling, this probe was used in gel
retardation experiments with nuclear extracts of HSV-1 infected
- 1 0 0 - 9 0 - 8 0
TACCQACCACACCQACQAATCCCC
TAGGGQATggfiTOOTGTGGCykrr T
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Figure 3. Gel mobility shift assay with 5' and 3 ' elements of gD site II. A. The
complete sequence of the site II region is shown, with the 5' and 3' core elements
of the consensus binding site marked by arrows. The extents of the 5' and 3'
oligonucleotide probes are shown by horizontal lines. B. The upper strand of
each synthetic oligonucleotide was labelled with 7-32P ATP and polynucleotide
kinase, annealed with the complementary lower strand and the double stranded
probe incubated with infected cell nuclear extract or ICP4 fraction VIII. In this
experiment 400ng lac DNA was used as non-specific competitor. The effects of
adding anti-ICP4 monoclonal antibody (mAb) or 200ng of unlabelled 47bp
fragment DNA were also determined. The percentage of oligonucleotide probe
in the specific ICP4 complex (indicated by the arrow) is shown beneath each lane.
cells. As with the 47bp fragment probe, complex formation
between the oligonucleotide probe and a component of the nuclear
extract was observed (Figure 5). This complex was shown to
be ICP4-specific by the fact that it was not observed with extracts
from mock infected cells and that it could be further retarded
by the addition of an anti-ICP4 antibody (data not shown).
The sequence requirements for the binding of ICP4 to the
oligonucleotide probe were investigated by synthesising a family
of related probes with mutations at various positions. These
mutations are shown in Figure 1. The results (Figure 5) show
that mutation of the first five positions of the ATCGTC consensus
resulted in large reductions in ICP4 complex formation (lanes
B to F). However, mutation of the final C to an A had little effect
(compare lanes A and G). The sequence requirement at this
position was further investigated using oligonucleotides with
changes to G or T. Again, the results indicate that these changes
did not severely affect binding by ICP4 (lanes H and J). It is
interesting that methylation of the G residue on the other strand
at this position in the normal sequence interfered with ICP4
binding (Figure 4) whereas alteration of this base did not.
Therefore the interference with binding by methylation at this
position is more likely to be due to steric effects rather than a
requirement for recognition of a specific base. An oligonucleotide
with three changes in the distal part of the consensus sequence
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Figure 4. Methylation interference of ICP4 binding to gD site II. A synthetic
double stranded oligonucleotide of the site II region was singly end- labelled on
the lower strand (panel A) or upper strand (panel B) and partially methylated
with dimethyl sulphate. The probe was then incubated with infected cell extract
and the free and ICP4 bound species separated by gel retardation. After elution
from the gel and treatment with piperidine, equalised counts of the free and unbound
probes were analysed on a 10% acrylamide DNA sequencing gel. The sequence
of the probe is shown next to the autoradiograph, with die ATCGTC core consensus
marked by vertical lines. Part C shows the helical 3 dimensional structure of
the site II region, with the important G residues marked in circles. Residues marked
in boxes represent the Gs in the 3' side of the site II sequence which are in positions
corresponding to the critical Gs in the 5' sequence. The proximal core consensus
is shown as a shaded section of the helix. The G residues implicated in binding
are marked with filled triangles or diamonds.
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Figure 5. Effect of point mutations in the gD site II region on binding of ICP4.
Mobility shift assays were conducted with oligonucleotide probes containing point
mutations in the site II region, using 5/*g of nuclear extract and 250ng 40bp lac
non-specific competitor DNA. The ICP4 DNA complex is indicated by an arrow.
The fraction of oligonucleotide probe in the ICP4 complex is indicated below
each lane
Figure 6. Binding of bacterial expression peptide I9X and 11 OX to gD site II
oligonucleotide probes. The lower panel shows gel retardation experiments using
11 OX protein with (tracks 1 to 10 respectively) the wild type oligonucleotide probe
and mutant oligos 2 - 6 , 1, 7, 9 and 8 respectively. Track 11 contains the wild
type probe with an extract containing the IIIX protein and track 12 probe alone.
The free probe and the specific retarded complex bands are marked. In the upper
panel the same probes have been used with an extract containing the I9X
polypeptide. Only the region of the gel with the specific retarded bands is shown.
did not form a complex with ICP4 (Figure 5, lane K). This
illustrates the importance of both the proximal (ATCGT) and
distal (YCG) parts of the consensus and indicates that not all
sequences which include the ATCGTC motif will be bound by
ICP4. This finding is consistent with a previous observation (20).
Alterations in the DNA binding domain of ICP4 can affect
the specificity of its binding to DNA
A combination of mutational and functional studies have shown
that the DNA binding domain of ICP4 lies within amino acid
residues approximately 250-500 (16-18, 28, 29). As a first
step towards identifying in more detail residues within this region
which are directly involved in specific DNA recognition,
fragments of this coding region were inserted into a bacterial
expression vector and the resultant ICP4 peptides partially
purified (as described in the Methods section). The ICP4 related
proteins expressed by pT7I9X, pT7I10X and pT7Ill contain
residues 252-523, 276-523 and 293-523 respectively; all were
expressed in amounts sufficient to be visible on an acrylamide
gel stained with Coomassie Blue (data not shown).
Gel retardation experiments using extracts containing the
protein expressed by pT719X gave a similar spectrum of DNA
binding specificity to that of intact ICP4 (Compare Figures 5 and
6). Mutations in the first five positions of the ATCGTC motif,
and the mutation in the distal portion of the consensus, all greatly
reduced binding. Extracts containing the protein expressed by
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plasmid pT7Ill, encompassing ICP4 residues 293-523, failed
to form a complex with the probes (data not shown). This
illustrates that the binding activity in the I9X extract is due to
the I9X protein (rather than a bacterial protein). These results
are consistent with the observations of Wu and Wilcox (28) who
showed that a bacterial fusion protein containing residues
262 —490 was able to bind to DNA specifically whereas a shorter
fusion including residues 306—490 was not.
The results with the protein expressed by plasmid pT7I10X
were similar to those obtained with the I9X protein, but with
some intriguing differences. Most prominent is the observation
that the II OX protein is able to bind quite efficiently when the
fifth position of the ATCGTC motif is mutated (Figure 5). In
addition, the triple mutation in the distal part of the complex
apparently abolished binding by I9X but not by the I10X protein.
Therefore the specificity of DNA sequence recognition has been
slightly altered by the removal of residues 252- 275 from the
bacterially expressed protein, which suggests that this highly basic
part of the polypeptide may be close to the site of nucleotide
contact. This difference in binding specificity is not a result of
expression in bacteria per se since the relaxation of the
requirement for the fifth position of the consensus was also
observed using the fragment of virally expressed ICP4 which
can be liberated (29) by proteinase k treatment (data not shown).
A further difference between the I9X and I10X proteins was
that I9X was more difficult to isolate, with a greater percentage
being lost in the insoluble pellet. Therefore IIOX extracts
contained significantly more expression protein than I9X extracts;
this probably explains (at least in part) why the II OX retarded
bands were more readily detectable (Figure 6).
DISCUSSION
The results presented in this paper show that both proximal and
distal parts of the ICP4 consensus DNA binding site are important
for specific binding but that strict conservation of the core
ATCGTC motif is not. It is also apparent that not all guanosine
residues which are identified as part of the ICP4 binding site by
methylation interference are actually involved in sequence specific
recognition. These results confirm and extend previous
observations that the first two bases of the ATCGTC motif are
important for binding (16, 20) and that the ATCGTC motif of
itself is insufficient to allow binding by ICP4 (20). This
information will allow more accurate prediction of the location
of ICP4 binding sites within the HSV-1 genome, which will in
turn be important in determining their role.
How the type of consensus site investigated here relate to other
less obviously related binding sequences is unclear. Michael and
Roizman (14) have identified two sites in the upstream portion
of the IE-3 promoter which apparently do not conform to the
ATCGTC consensus. However, examination of one of these sites
(which can be written as ATGGGCnnnnCCGG) in the light of
our data suggests that it may not be unusual. Both changes from
consensus in the ATCGTC motif are at positions where mutations
in gD site II did not totally eliminate binding (Figures 5 and 6).
The other (which can be written as GCCGGCnnnnCGG) is less
similar to the ATCGTC consensus. However, other such GC-
rich ICP4 binding sites have also been detected in the gC
promoter region (our unpublished results). A strict comparison
of these apparently different classes of site requires careful
determination of relative binding constants, and a more thorough
mutagenic study will be necessary for further determination of
the precise DNA sequence requirements for binding by ICP4.
The observation that the bacterial expression protein I9X has
a sequence requirement for DNA binding essentially
indistinguishable from that of authentic ICP4 reinforces a previous
conclusion (28) that post translational modification has no
apparent role in DNA binding by ICP4. Therefore, the bacterial
expression system should prove ideal for the determination of
the precise amino acid residues of ICP4 that are involved in
sequence specific recognition. The results with the IIOX protein
suggest that these sequences may lie close (either in sequence
or in three dimensional structure) to residues 253—272 (which
affect specificity) and residues 273—291 (which are required for
binding). It is intriguing that these segments of ICP4 are just
outside a region which is very highly conserved in all members
of the ICP4 family of proteins (30-32). Therefore differences
in amino acid sequence in the less highly conserved part of the
DNA binding domain could contribute to the differences in detail
in the properties and functions of these proteins, through alteration
of their DNA binding properties.
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